Strain Name:
B6.Cg-Tcratm1Mom Tg(TcrLCMV)327Sdz/TacMmjax
Stock Number:
037394-JAX
Citation ID:
RRID:MMRRC_037394-JAX

Strain Information

Tcratm1Mom
Name: T cell receptor alpha chain; targeted mutation 1, Peter Mombaerts
Synonyms: TCRalpha KO, TCR alpha-, TCR alpha0, alpha-, TCRmini, TCRalpha-, TCR Calpha-, C-alpha-
Type: Allele
Species: Mus musculus (mouse)
Chromosome: 14
Alteration at locus: Knockout
Tcra
Name: T cell receptor alpha chain
Synonyms: Tcr alpha, Tcralpha
Type: Gene
Species: Mus musculus (mouse)
Chromosome: 14
Alteration at locus: Transgenic
Tg(TcrLCMV)327Sdz
Name: transgene insertion 327, Birgit Ledermann
Synonyms: P14 TCRValpha2Vbeta8, P14-TCR, P14 TCR-alphabeta (Valpha2Vbeta8.1), TCR P14, TCR-Tg, P14 TCR, TCR LCMV, TgTcr, P14
Type: Allele
Species: Mus musculus (mouse)
Chromosome: UN
Alteration at locus: Transgenic
Tcrb
Name: T cell receptor beta chain
Synonyms: Tib, TCRbeta
Type: Gene
Species: Mus musculus (mouse)
Chromosome: 6
Alteration at locus: Transgenic
Genetic Alterations

The Tcrα knockout/transgenic LCMV P14 T cell receptor line is homozygous for a transgene that encodes a T cell receptor that is specific for a peptide (P14) from the lymphocytic choriomeningitis virus (LCMV) presented by the MHC class I molecule H-2Db. The transgene carries both Tcra and Tcrb. Ten to twenty copies of the Tcr transgene were reported to have integrated on the same chromosome. At least two transgenic lines are known to exist. Line 327 is the representative line. The second line is 318. This line is also deficient in the Tcrα gene and, therefore, does not develop endogenous mature TCR alpha beta cells.


ES Cell Line
D3 derived from 129S2/SvPas
Phenotype
Almost all the peripheral T cells are CD8+ and express the transgenic TCR. The mice are useful for in vitro studies of CD8+ T cell activation and differentiation to cytotoxic lymphocytes and as a source of donor cells for adoptive transfer into B6 mice for in vivo studies of inflammation, tolerance, and anti-viral responses. In contrast to Taconic's model 4113, which expresses the TCR transgene on a Rag2-/- background, these mice express normal numbers of B cells and TCRγδ T cells.
Mammalian Phenotype Terms
Allelic Composition: (Genetic Background: )

Allelic Composition: (Genetic Background: )

MeSH Terms
  • Animals
  • Antigens, Differentiation, T-Lymphocyte
  • Antigens, Surface/immunology
  • Antigens, Viral/immunology
  • CD4-Positive T-Lymphocytes/immunology
  • CD8 Antigens
  • Cytotoxicity, Immunologic
  • Immune Tolerance
  • Lymphocytic choriomeningitis virus/immunology
  • Mice
  • Mice, Transgenic/immunology
  • Minor Lymphocyte Stimulatory Antigens
  • Spleen/immunology
  • T-Lymphocytes, Cytotoxic/immunology
  • Thymus Gland/cytology
  • Thymus Gland/immunology
  • CD4-CD8 Ratio
  • CD4-Positive T-Lymphocytes/physiology
  • CD8 Antigens/physiology
  • Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor/genetics
  • Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor/physiology
  • Gene Rearrangement, beta-Chain T-Cell Antigen Receptor/genetics
  • Gene Rearrangement, beta-Chain T-Cell Antigen Receptor/physiology
  • Genes, RAG-1/genetics
  • Leukocyte Count
  • Mice, Inbred BALB C
  • Mice, Mutant Strains
  • Mice, Transgenic
  • Mutation
  • Thymus Gland/growth & development
Strain Development

The transgenic LCMV-P14 T cell receptor transgenic mouse was made by Dr. Hanspeter Pircher and colleagues in 1989 at the Department of Experimental Pathology in Zurich, Switzerland. The transgenic line was created by coinjection of the P14 Tcrα and Tcrβ gene constructs into (C57BL/6 x DBA/2)F2-fertilized eggs. The male founder 327, who had 10-20 copies of both transgenes integrated onto the same chromosome, was crossed to a C57BL/6 female. The line was subsequently backcrossed to C57BL/6 up to N10 and then intracrossed to establish a homozygous line. These mice were brought to Taconic in May of 1997 by Dr. B.J. Fowlkes and embryo transfer-derived into the NIAID colony. In 1998, this strain was crossed twice to TCRa-targeted mutation mice (B6.129S2-Tcratm1Mom N12). The Tcra knockout line was developed in the laboratory of Dr. S. Tonegawa by Dr. P. Mombaerts in 1992 by targeting in 129S2/SvPas-derived D3 ES cells and subsequently backcrossed to C57BL/6 12 times. After the second cross to the Tcra-/- strain, mice homozygous for the Tcra mutation were selected by looking for the disappearance of endogenous CD4+ T cells using FACS analysis. The line was then bred to obtain mice homozygous for the transgene followed by selection using test crosses and FACS analysis to identify mice exhibiting high levels of expression of the Vβ 8.1, Vα 2 transgene.

The line was donated to the MMRRC in 2014.

MMRRC Genetic QC Summary
The MMRRC Centers have developed a genetic QC pipeline using MiniMUGA array genotyping to provide additional information on strain backgrounds for MMRRC congenic and inbred strains. For more information on when data may be available, or to request genotyping for a strain of interest, please contact csmmrrc@jax.org. Older strains may not have this information.
  • Inflammation
  • Tolerance
  • Anti-viral responses

    Donor
    Susumu Tonegawa, Ph.D., Massachusetts Institute of Technology.
    Peter Mombaerts, M.D., Max Planck Research Unit for Neurogenetics.
    Birgit Ledermann, Ph.D., Novartis Institutes for BioMedical Research (NIBR).
    Primary Reference

    Pircher H, Burki K, Lang R, Hengartner H, Zinkernagel RM. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature. 1989 Nov 30;342(6249):559-61. (Medline PMID: 2573841)

    Mombaerts P, Clarke AR, Rudnicki MA, Iacomini J, Itohara S, Lafaille JJ, Wang L, Ichikawa Y, Jaenisch R, Hooper ML, et al. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature. 1992 Nov 19;360(6401):225-31. (Medline PMID: 1359428)

    Colony and Husbandry Information

    For more information about this colony's health status contact csmmrrc@jax.org
    Coat Color
    Black
    MMRRC Breeding System
    Backcross
    Generation
    see Development section
    NOTE: "Hemizygote" as used here refers to males carrying a mutation on the X Chromosome or mice of either sex carrying an inserted transgene with no homologous allele on the other chromosome.
    Viability and Fertility: Female Male Comments
    Homozygotes are viable: Yes Yes
    Homozygotes are fertile: Unknown Unknown
    Hetero/Hemizygotes are fertile: Yes Yes
    Age Reproductive Decline: Undetermined Undetermined
    Bred to Homozygosity
    Yes
    Average litter size
    Undetermined

    Order Request Information

    The availability level for this product has not been determined.

    Distribution of this strain requires submission of the MMRRC Conditions of Use (COU). A link to the COU web form will be provided via email after an order has been placed; the form should be completed then or the email forwarded to your institutional official for completion.

    The donor or their institution limits the distribution to non-profit institutions only.

    - Products for this strain are Not Yet Available for Ordering
    - If you register interest in this strain, you will be notified when it becomes available for ordering.

    To request material from the MMRRC: Please fill out our on-line request form (accessible from the catalog search results page, or click the Request this Strain button in the fees section). If you have questions or need assistance completing this form, you may call Customer Service at (800) 910-2291 (in USA or Canada) or (530) 757-5710 (international calls). Before you call, please have with you: the MMRRC item number, quantity needed, Bill-to and Ship-to contact information.